These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 1376778)

  • 61. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.
    Cobb JP; Natanson C; Hoffman WD; Lodato RF; Banks S; Koev CA; Solomon MA; Elin RJ; Hosseini JM; Danner RL
    J Exp Med; 1992 Oct; 176(4):1175-82. PubMed ID: 1383377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin 1 beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases.
    Reimers JI; Bjerre U; Mandrup-Poulsen T; Nerup J
    Cytokine; 1994 Sep; 6(5):512-20. PubMed ID: 7530059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP.
    Hirokawa K; O'Shaughnessy K; Moore K; Ramrakha P; Wilkins MR
    Br J Pharmacol; 1994 Jun; 112(2):396-402. PubMed ID: 7521256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
    Welsh N; Eizirik DL; Bendtzen K; Sandler S
    Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.
    Rockey DC; Chung JJ
    J Clin Invest; 1995 Mar; 95(3):1199-206. PubMed ID: 7533786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells.
    Schini VB; Durante W; Catovsky S; Vanhoutte PM
    J Vasc Res; 1993; 30(4):209-17. PubMed ID: 8357951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reversible inactivation of endothelial nitric oxide synthase by NG-nitro-L-arginine.
    Mayer B; Schmid M; Klatt P; Schmidt K
    FEBS Lett; 1993 Oct; 333(1-2):203-6. PubMed ID: 7693510
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
    Ikeda U; Shimada K
    Eur J Pharmacol; 1994 Nov; 269(3):319-23. PubMed ID: 7534708
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
    Lin PJ; Chang CH; Chang JP
    Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of guanidino and uremic compounds on nitric oxide pathways.
    MacAllister RJ; Whitley GS; Vallance P
    Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hemoglobin augmentation of interleukin-1 beta-induced production of nitric oxide in smooth-muscle cells.
    Suzuki S; Takenaka K; Kassell NF; Lee KS
    J Neurosurg; 1994 Dec; 81(6):895-901. PubMed ID: 7965120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
    Kilbourn RG; Belloni P
    J Natl Cancer Inst; 1990 May; 82(9):772-6. PubMed ID: 2109093
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cells.
    Paul A; Bryant C; Lawson MF; Chilvers ER; Plevin R
    Br J Pharmacol; 1997 Apr; 120(8):1439-44. PubMed ID: 9113363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
    Kilbourn RG; Fonseca GA; Trissel LA; Griffith OW
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S21-30. PubMed ID: 10685654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells.
    Schini VB; Durante W; Elizondo E; Scott-Burden T; Junquero DC; Schafer AI; Vanhoutte PM
    Eur J Pharmacol; 1992 Jun; 216(3):379-83. PubMed ID: 1385162
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells.
    Geng YJ; Petersson AS; Wennmalm A; Hansson GK
    Exp Cell Res; 1994 Sep; 214(1):418-28. PubMed ID: 7521848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lipoteichoic acid: a new inducer of nitric oxide synthase.
    Lonchampt MO; Auguet M; Delaflotte S; Goulin-Schulz J; Chabrier PE; Braquet P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S145-7. PubMed ID: 1282952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.